Allert ta' Periklu: Pinna Ozempic Falza F'Malta
Allert ta' Periklu: Pinna Ozempic Falza F'Malta
L-awtoritajiet tas-saħħa f’Malta ħarġu Allert Nazzjonali għas-Sigurtà tal-Pazjent, wara li pakkett ta’ pinen tal-injezzjoni Ozempic® 1mg ġie suspettat li hu falz. Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq, Novo Nordisk®, kien hu li rrapporta l-kwistjoni lill-Awtorità Maltija dwar il-Mediċini, li min-naħa tagħha bdiet proċedura ta’ irtirar bħala miżura ta' prekawzjoni. Din l-azzjoni tkopri biss il-lott speċifiku bin-numru PP5N682::RN287, b'data ta' skadenza fi Frar 2027. Ebda lott ieħor m'hu affettwat.
Ozempic, magħruf ukoll bħala semaglutide, huwa primarjament mediċina użata biex tikkontrolla l-livelli taz-zokkor fid-demm f’adulti bid-dijabete tat-tip 2. Madankollu, il-popolarità tiegħu żdiedet bil-kbir minħabba l-effett sekondarju ta’ telf ta’ piż, u dan wassal għal domanda għolja u nuqqasijiet okkażjonali fil-provvista. Din id-domanda qawwija ħolqot suq perikoluż għal prodotti ffalsifikati. Fil-fatt, din mhijiex l-ewwel darba li l-produttur kellu joħroġ twissija simili.
L-stakes huma għoljin:
*
X'inhuma eżattament il-mediċini ffalsifikati? Huma prodotti manifatturati illegalment li jirrappreżentaw b'mod falz l-identità, il-kompożizzjoni jew is-sors tagħhom. Dawn jistgħu ma jkunux fihom l-ebda ingredjent attiv, l-ingredjent ħażin, jew sustanzi li potenzjalment huma ta' ħsara.
*
Ir-Riskju ta' Infezzjoni: Analiżi fuq prodotti ffalsifikati misjuba f’partijiet oħra tad-dinja wriet li l-labar tal-pinna kienu wkoll iffalsifikati. Il-isterilità ta' dawn il-labar ma tistax tiġi garantita, u dan jippreżenta riskju akbar ta' infezzjoni.
*
Konsegwenzi Perikolużi għas-Saħħa: L-użu ta’ mediċina falza jista’ jwassal għal nuqqas ta’ effett terapewtiku, u jista’ wkoll jikkawża effetti sekondarji serji minħabba sustanzi mhux magħrufa.
Il-messaġġ mill-awtoritajiet huwa ċar u mingħajr dubju: jekk għandek Ozempic minn dan il-lott, waqqaf l-użu immedjatament. Il-ħajja hija prijorità, mhux il-piż.
Jekk għandek Ozempic® minn dan il-lott, għandek tagħmel dan:
*
Waqqaf l-użu tiegħu immedjatament.
*
Ikkuntattja lill-ispiżerija tiegħek biex tivverifika n-numru tal-lott.
*
Irritorna l-pakkett lill-ispiżerija minn fejn xtrajtu.
*
Kellem lill-ispiżjar jew lit-tabib tiegħek biex titkellem dwar il-kontinwazzjoni tal-kura tiegħek.
Is-Supretendent tas-Saħħa Pubblika u l-Awtorità Maltija dwar il-Mediċini qed jaħdmu mal-partijiet interessati kollha biex jissalvagwardjaw is-saħħa pubblika.
Sorsi:
*
Lovin Malta (lovinmalta.com)
*
Times of Malta (timesofmalta.com)
*
Newsbook Malta (newsbook.com.mt)
*
Awtorità Maltija dwar il-Mediċini (medicinesauthority.gov.mt)
*
Novo Nordisk (novonordisk.com)
Aħna naqilgħu minn xiri kwalifikat permezz ta' din il-link tal-Amazon: https://amzn.to/3Avoaxz. Lest biex tidħol aktar fil-fond fit-temi li qed niddiskutu? Appoġġa x-xogħol tagħna billi tikklikkja fuq il-link affiljat tagħna tal-Amazon għax-xiri li jmiss tiegħek! Kull klikk tgħinna nġibulek aktar kontenut insightful.
---
Urgent Recall: Falsified Ozempic Pen in Malta
Malta's health authorities have issued a National Patient Safety Alert after a pack of Ozempic® 1mg injection pens was suspected to be falsified. The marketing authorization holder, Novo Nordisk®, was the one who reported the issue to the Malta Medicines Authority, which in turn initiated a precautionary recall procedure. This action only covers the specific batch with the number PP5N682::RN287, with an expiry date of February 2027. No other batches are affected.
Ozempic, also known as semaglutide, is primarily a medicine used to control blood sugar levels in adults with type 2 diabetes. However, its popularity has skyrocketed due to the side effect of weight loss, which has led to high demand and occasional supply shortages. This intense demand has created a dangerous market for falsified products. In fact, this is not the first time the manufacturer has had to issue a similar warning.
The stakes are high:
*
What exactly are falsified medicines? They are illegally manufactured products that deliberately misrepresent their identity, composition, or source. They may contain no active ingredients, the wrong ingredient, or potentially harmful substances.
*
Risk of Infection: Analysis of falsified products found in other parts of the world showed that the pen needles were also counterfeit. The sterility of these needles cannot be guaranteed, which presents an increased risk of infection.
*
Dangerous Health Consequences: The use of a fake medicine can lead to a lack of therapeutic effect and can also cause serious side effects due to unknown substances.
The message from the authorities is clear and unambiguous: if you have Ozempic from this batch, stop using it immediately. Life is a priority, not weight.
If you have Ozempic® from this batch, you must do the following:
*
Stop using it immediately.
*
Contact your pharmacy to verify the batch number.
*
Return the pack to the pharmacy where it was purchased.
*
Speak to your pharmacist or doctor to discuss the continuation of your treatment.
The Superintendent of Public Health and the Malta Medicines Authority are working with all relevant stakeholders to safeguard public health.
Sources:
*
Lovin Malta (lovinmalta.com)
*
Times of Malta (timesofmalta.com)
*
Newsbook Malta (newsbook.com.mt)
*
Malta Medicines Authority (medicinesauthority.gov.mt)
*
Novo Nordisk (novonordisk.com)
We earn from qualifying purchases through this Amazon link: https://amzn.to/3Avoaxz. Ready to dive deeper into the topics we're discussing? Support our work by clicking on our Amazon affiliate link for your next purchase! Every click helps us bring you more insightful content.